Pancreatic Cancer Research

ResearcherLeiden University Medical CenterActive in the last 2 years

Peter J.K. Kuppen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0294-3251; OpenAlex author ID A5058922925. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 9

  1. Evaluation of tumor targets selected from public genomic databases for imaging of pancreatic ductal adenocarcinoma. Last author DOI 10.1038/s41598-025-00517-1↗
  2. Prediction of Biomarker Expression on Primary Pancreatic Ductal Adenocarcinoma Tissues Using Fine-Needle Biopsies: Paving the Way for a Patient-Tailored Molecu… Last author DOI 10.1007/s40291-022-00635-w↗
  3. An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13225777↗
  4. Overview and Future Perspectives on Tumor-Targeted Positron Emission Tomography and Fluorescence Imaging of Pancreatic Cancer in the Era of Neoadjuvant Therapy. Co-author DOI 10.3390/cancers13236088↗
  5. Molecular targets for diagnostic and intraoperative imaging of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX treatment. Co-author DOI 10.1038/s41598-020-73242-6↗
  6. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer. Co-author DOI 10.1126/sciadv.aax2770↗
  7. Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells. Co-author DOI 10.1177/1177271917715443↗
  8. Selection of optimal molecular targets for tumor-specific imaging in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.18232↗
  9. Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery. Last author DOI 10.1007/s11307-016-0959-4↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alexander L. Vahrmeijer · 9 shared papers, 2016–2025 · strength 0.99
  2. J. Sven D. Mieog · 7 shared papers, 2016–2025 · strength 0.84
  3. Cornelis F.M. Sier · 8 shared papers, 2016–2023 · strength 0.74
  4. Bert A. Bonsing · 7 shared papers, 2016–2023 · strength 0.66
  5. Ruben D. Houvast · 4 shared papers, 2021–2025 · strength 0.64
  6. Lysanne D. A. N. de Muynck · 2 shared papers, 2020–2025 · strength 0.34
  7. Rutger‐Jan Swijnenburg · 4 shared papers, 2016–2021 · strength 0.32
  8. Nada Badr · 1 shared paper, 2025 · strength 0.25
  9. Floris A. Vuijk · 2 shared papers, 2020–2021 · strength 0.20
  10. Susanna W.L. de Geus · 3 shared papers, 2016–2019 · strength 0.20
  11. Jeanin Elise van Hooft · 1 shared paper, 2023 · strength 0.16
  12. Jesse V. Groen · 1 shared paper, 2021 · strength 0.12
  13. Hans Morreau · 2 shared papers, 2016–2017 · strength 0.12
  14. Willemieke S. F. J. Tummers · 2 shared papers, 2016–2017 · strength 0.11
  15. Martijn A. van Dam · 1 shared paper, 2021 · strength 0.11
  16. Johanna W. Wilmink · 1 shared paper, 2020 · strength 0.09
  17. Joanne Verheij · 1 shared paper, 2020 · strength 0.09
  18. Marc G. Besselink · 1 shared paper, 2020 · strength 0.09
  19. Jonas Schnittert · 1 shared paper, 2019 · strength 0.08
  20. Praneeth Reddy Kuninty · 1 shared paper, 2019 · strength 0.08
  21. Deby Fajar Mardhian · 1 shared paper, 2019 · strength 0.08
  22. Hanneke W.M. van Laarhoven · 1 shared paper, 2019 · strength 0.08
  23. Arne Östman · 1 shared paper, 2019 · strength 0.08
  24. Jai Prakash · 1 shared paper, 2019 · strength 0.08
  25. Maarten F. Bijlsma · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.